Literature DB >> 12464114

Activation of the cannabinoid CB1 receptor may involve a W6 48/F3 36 rotamer toggle switch.

R Singh1, D P Hurst, J Barnett-Norris, D L Lynch, P H Reggio, F Guarnieri.   

Abstract

The cannabinoid CB1 receptor, a member of the Rhodopsin (Rho) family of G protein coupled receptors (GPCRs), exhibits high levels of constitutive activity. In contrast, Rho exhibits an exquisite lack of constitutive activity. In Rho, W6.48(265) on transmembrane helix 6 (TMH6) is flanked by aromatic residues at positions i-4 (F6.44) and i + 3 (Y6.51), while in CB1 the residues i-4 and i + 3 to W6.48 are leucines (L6.44 and L6.51). Based upon spectroscopic evidence, W6.48 has been proposed to undergo a rotamer switch (chi1 g+ -->trans) upon activation of Rho. In the work reported here, the biased Monte Carlo method, Conformational Memories (CM) was used to test the hypothesis that the high constitutive activity exhibited by CB1 may be due, in part, to the lack of aromatic residues i-4 and i + 3 from W6.48. In this work, the W6.48 rotamer shift (chi1 g+ -->trans) was used as the criterion for activation. Conformational Memories (CM) calculations on WT CB1 TMH6 and L6.44F and L6.51Y mutant TMH6s revealed that an aromatic residue at 6.44 tends to disfavor the W6.48 chi1 g+ -->trans transition and an aromatic residue at 6.51 would require a concomitant movement of the Y6.51 chi1 from trans-->g+ when the W6.48 chi1 undergoes a g+ -->trans shift. In contrast, CM calculations on WT CB1 TMH6 revealed that the presence of leucines at 6.44 and 6.51 provide W6.48 with greater conformational mobility, with a W6.48 transchi1 preferred. Conformational Memories calculations also revealed that the W6.48 chi1 g+ -->trans transition in WT CB1 TMH6 is correlated with the degree of kinking in TMH6. The average proline kink angles for TMH6 were higher for helices with a W6.48 g+ chi1 than for those with a W6.48 transchi1. These results are consistent with experimental evidence that TMH6 straightens during activation. Transmembrane helix (TMH) bundle models of the inactive (R) and active (R*) states of CB1 were then probed for interactions that may constrain W6.48 in the inactive state of CB1. These studies revealed that F3.36 (transchi1) helps to constrain W6.48 in a g+ chi1 in the inactive (R) state of CB1. In the R* state, these studies suggest that F3.36 must assume a g+ chi1 in order to allow W6.48 to shift to a transchi1. These results suggest that the W6.48/F3.36 interaction may act as the 'toggle switch' for CB1 activation, with W6.48 chi1 g+/F3.36 chi1 trans representing the inactive (R) and W6.48 chi1 trans/F3.36 chi1 g+ representing the active (R*) state of CB1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464114     DOI: 10.1034/j.1399-3011.2002.21065.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  26 in total

1.  Coupling of retinal isomerization to the activation of rhodopsin.

Authors:  Ashish B Patel; Evan Crocker; Markus Eilers; Amiram Hirshfeld; Mordechai Sheves; Steven O Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

2.  A method for structural analysis of alpha-helices of membrane proteins.

Authors:  Pranab K Mohapatra; Adikanda Khamari; Mukesh K Raval
Journal:  J Mol Model       Date:  2004-11-04       Impact factor: 1.810

Review 3.  Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers.

Authors:  Patricia H Reggio
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

Review 4.  Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors.

Authors:  Harel Weinstein
Journal:  AAPS J       Date:  2006-01-06       Impact factor: 4.009

Review 5.  Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands.

Authors:  A Poso; J W Huffman
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

6.  A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.

Authors:  A J Kooistra; S Kuhne; I J P de Esch; R Leurs; C de Graaf
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 7.  Cannabinoid receptors: nomenclature and pharmacological principles.

Authors:  Linda Console-Bram; Jahan Marcu; Mary E Abood
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-28       Impact factor: 5.067

8.  Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations.

Authors:  Caitlin E Scott; Ravinder Abrol; Kwang H Ahn; Debra A Kendall; William A Goddard
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

9.  Analysis of the activation mechanism of the guinea-pig Histamine H1-receptor.

Authors:  Andrea Strasser; Hans-Joachim Wittmann
Journal:  J Comput Aided Mol Des       Date:  2007-08-22       Impact factor: 3.686

10.  Molecular dynamics of fentanyl bound to μ-opioid receptor.

Authors:  Piotr F J Lipiński; Małgorzata Jarończyk; Jan Cz Dobrowolski; Joanna Sadlej
Journal:  J Mol Model       Date:  2019-05-03       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.